PetLife Pharmaceuticals Rebrands all Products in Preparation for The FDA Registration Process
August 19, 2016 11:40 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Aug. 19, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for...
PetLife Pharmaceuticals, Inc. Issues Letter to Shareholders
August 16, 2016 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD , Aug. 16, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for...
PetLife Pharmaceuticals Holds First Medical Professional Investor Conference
August 01, 2016 08:30 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Aug. 01, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for...
PetLife Pharmaceuticals Adds Seasoned Medical Professionals to the Management Team
July 25, 2016 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, July 25, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
PetLife Pharmaceuticals Retains Invicto Group as their Investor Relations Firm
July 19, 2016 09:47 ET
|
PetLife Pharmaceuticals, Inc.
HANCOOK, Md., July 19, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB:PTLF), a developer of new generation of high potency veterinary cancer medications and nutraceuticals...
PetLife Pharmaceuticals Provides Positive Update to Shareholders
October 05, 2015 09:06 ET
|
PetLife Pharmaceuticals, Inc.
Highlights:
Expected to appoint new management team
Plans to launch initial distribution of new product line
Expects to finalize significant financing
BEVERLY HILLS, Calif., Oct. 5,...